CD163 and neoplasm: The tumor tissues presenting VAP-1/CD68, VAP-1/iNOS, and VAP-1/CD163 coexpression were detected in 47 (43.52%), 29 (26.85%), and 49 (45.37%) specimens respectively (Table 2).